Asset Management One Co. Ltd. Trims Stock Holdings in Humana Inc. (NYSE:HUM)

Asset Management One Co. Ltd. lessened its stake in shares of Humana Inc. (NYSE:HUM) by 1.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 53,644 shares of the insurance provider’s stock after selling 784 shares during the quarter. Asset Management One Co. Ltd.’s holdings in Humana were worth $13,714,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in the company. International Assets Investment Management LLC grew its holdings in shares of Humana by 261,025.1% during the third quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider’s stock worth $2,340,660,000 after buying an additional 738,701 shares in the last quarter. FMR LLC raised its holdings in Humana by 23.4% in the 3rd quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock valued at $1,073,387,000 after acquiring an additional 643,291 shares during the last quarter. Thrivent Financial for Lutherans lifted its stake in shares of Humana by 55.6% during the 3rd quarter. Thrivent Financial for Lutherans now owns 600,317 shares of the insurance provider’s stock worth $190,145,000 after purchasing an additional 214,535 shares during the period. Retirement Systems of Alabama boosted its holdings in shares of Humana by 735.9% during the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock worth $55,563,000 after purchasing an additional 192,801 shares during the last quarter. Finally, Pzena Investment Management LLC increased its stake in Humana by 8.1% in the third quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider’s stock valued at $793,830,000 after purchasing an additional 187,903 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Ratings Changes

A number of analysts have issued reports on the company. Royal Bank of Canada reissued an “outperform” rating and issued a $283.00 price target on shares of Humana in a research note on Wednesday, February 12th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $290.00 price target on shares of Humana in a research note on Wednesday, February 12th. Piper Sandler lifted their price target on shares of Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a report on Wednesday, January 15th. Barclays increased their target price on Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a research report on Thursday. Finally, Wells Fargo & Company dropped their price target on Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a research note on Monday, November 4th. Nineteen analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, Humana currently has an average rating of “Hold” and a consensus target price of $293.05.

Insider Buying and Selling at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the sale, the insider now directly owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.32% of the stock is currently owned by insiders.

Humana Price Performance

Shares of NYSE HUM opened at $253.61 on Monday. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The business has a 50 day moving average price of $271.27 and a two-hundred day moving average price of $293.44. The firm has a market cap of $30.54 billion, a PE ratio of 22.46, a price-to-earnings-growth ratio of 2.11 and a beta of 0.56.

Humana (NYSE:HUM) last released its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.18% and a return on equity of 13.20%. Sell-side analysts expect that Humana Inc. will post 16.11 earnings per share for the current fiscal year.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.